1bvg: Difference between revisions

From Proteopedia
Jump to navigationJump to search
OCA (talk | contribs)
New page: left|200px<br /> <applet load="1bvg" size="450" color="white" frame="true" align="right" spinBox="true" caption="1bvg" /> '''HIV-1 PROTEASE-DMP323 COMPLEX IN SOLUTION, ...
 
OCA (talk | contribs)
No edit summary
Line 1: Line 1:
[[Image:1bvg.gif|left|200px]]<br />
[[Image:1bvg.gif|left|200px]]<br /><applet load="1bvg" size="350" color="white" frame="true" align="right" spinBox="true"  
<applet load="1bvg" size="450" color="white" frame="true" align="right" spinBox="true"  
caption="1bvg" />
caption="1bvg" />
'''HIV-1 PROTEASE-DMP323 COMPLEX IN SOLUTION, NMR MINIMIZED AVERAGE STRUCTURE'''<br />
'''HIV-1 PROTEASE-DMP323 COMPLEX IN SOLUTION, NMR MINIMIZED AVERAGE STRUCTURE'''<br />


==Overview==
==Overview==
The three-dimensional solution structure of the HIV-1 protease homodimer, MW 22.2 kDa, complexed to a potent, cyclic urea-based inhibitor, DMP323, is reported. This is the first solution structure of an HIV, protease/inhibitor complex that has been elucidated. Multidimensional, heteronuclear NMR spectra were used to assemble more than 4,200 distance, and angle constraints. Using the constraints, together with a hybrid, distance geometry/simulated annealing protocol, an ensemble of 28 NMR, structures was calculated having no distance or angle violations greater, than 0.3 A or 5 degrees, respectively. Neglecting residues in disordered, loops, the RMS deviation (RMSD) for backbone atoms in the family of, structures was 0.60 A relative to the average structure. The individual, NMR structures had excellent covalent geometry and stereochemistry, as did, the restrained minimized average structure. The latter structure is, similar to the 1.8-A X-ray structure of the protease/DMP323 complex (Chang, CH et al., 1995, Protein Science, submitted); the pairwise backbone RMSD, calculated for the two structures is 1.22 A. As expected, the mismatch, between the structures is greatest in the loops that are disordered and/or, flexible. The flexibility of residues 37-42 and 50-51 may be important in, facilitating substrate binding and product release, because these residues, make up the respective hinges and tips of the protease flaps. Flexibility, of residues 4-8 may play a role in protease regulation by facilitating, autolysis.
The three-dimensional solution structure of the HIV-1 protease homodimer, MW 22.2 kDa, complexed to a potent, cyclic urea-based inhibitor, DMP323, is reported. This is the first solution structure of an HIV protease/inhibitor complex that has been elucidated. Multidimensional heteronuclear NMR spectra were used to assemble more than 4,200 distance and angle constraints. Using the constraints, together with a hybrid distance geometry/simulated annealing protocol, an ensemble of 28 NMR structures was calculated having no distance or angle violations greater than 0.3 A or 5 degrees, respectively. Neglecting residues in disordered loops, the RMS deviation (RMSD) for backbone atoms in the family of structures was 0.60 A relative to the average structure. The individual NMR structures had excellent covalent geometry and stereochemistry, as did the restrained minimized average structure. The latter structure is similar to the 1.8-A X-ray structure of the protease/DMP323 complex (Chang CH et al., 1995, Protein Science, submitted); the pairwise backbone RMSD calculated for the two structures is 1.22 A. As expected, the mismatch between the structures is greatest in the loops that are disordered and/or flexible. The flexibility of residues 37-42 and 50-51 may be important in facilitating substrate binding and product release, because these residues make up the respective hinges and tips of the protease flaps. Flexibility of residues 4-8 may play a role in protease regulation by facilitating autolysis.


==About this Structure==
==About this Structure==
1BVG is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Human_immunodeficiency_virus Human immunodeficiency virus] with DMP as [http://en.wikipedia.org/wiki/ligand ligand]. Active as [http://en.wikipedia.org/wiki/HIV-1_retropepsin HIV-1 retropepsin], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.4.23.16 3.4.23.16] Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=1BVG OCA].  
1BVG is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Human_immunodeficiency_virus Human immunodeficiency virus] with <scene name='pdbligand=DMP:'>DMP</scene> as [http://en.wikipedia.org/wiki/ligand ligand]. Active as [http://en.wikipedia.org/wiki/HIV-1_retropepsin HIV-1 retropepsin], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.4.23.16 3.4.23.16] Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1BVG OCA].  


==Reference==
==Reference==
Line 16: Line 15:
[[Category: Single protein]]
[[Category: Single protein]]
[[Category: Chang, C.]]
[[Category: Chang, C.]]
[[Category: Domaille, P.J.]]
[[Category: Domaille, P J.]]
[[Category: Hinck, A.P.]]
[[Category: Hinck, A P.]]
[[Category: Kaufman, J.D.]]
[[Category: Kaufman, J D.]]
[[Category: Lam, P.Y.S.]]
[[Category: Lam, P Y.S.]]
[[Category: Nicholson, L.K.]]
[[Category: Nicholson, L K.]]
[[Category: Stahl, S.J.]]
[[Category: Stahl, S J.]]
[[Category: Torchia, D.A.]]
[[Category: Torchia, D A.]]
[[Category: Wang, Y.X.]]
[[Category: Wang, Y X.]]
[[Category: Wingfield, P.]]
[[Category: Wingfield, P.]]
[[Category: Yamazaki, T.]]
[[Category: Yamazaki, T.]]
Line 34: Line 33:
[[Category: rna-directed dna polymerase]]
[[Category: rna-directed dna polymerase]]


''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Thu Nov  8 13:54:51 2007''
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 11:59:31 2008''